These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3695491)

  • 1. Characterization and biological relevance of a 29-kDa, oestrogen receptor-related protein.
    King RJ; Finley JR; Coffer AI; Millis RR; Rubens RD
    J Steroid Biochem; 1987; 27(1-3):471-5. PubMed ID: 3695491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological probes for oestradiol receptors in human breast tumours.
    King RJ; Cano A; Finley J; Coffer AI
    J Steroid Biochem; 1986 Jan; 24(1):369-72. PubMed ID: 3517498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of p29, an estrogen-receptor associated tumor marker.
    Coffer AI; King RJ
    J Steroid Biochem; 1988 Nov; 31(5):745-50. PubMed ID: 3199814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer.
    Ciocca DR; Luque EH
    Breast Cancer Res Treat; 1991 Dec; 20(1):33-42. PubMed ID: 1667487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoradiometric studies with a monoclonal antibody against an estrogen-receptor-related protein in human breast cancer.
    Cano A; Rivera J; Parrilla JJ; Abad L
    Gynecol Obstet Invest; 1988; 26(2):166-70. PubMed ID: 3220320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptionally active non-ligand binding oestrogen receptors in breast cancer.
    Marsigliante S; Greco S; Biscozzo L; Barker S; Baker V; Giuseppe L; Vinson GP; Storelli C
    Cancer Lett; 1992 Oct; 66(3):183-91. PubMed ID: 1451100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of P29, an oestrogen receptor-associated tumor marker, in human term placenta.
    Cano A; Rivera J
    Placenta; 1991; 12(2):153-60. PubMed ID: 1908078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p29 protein in breast cancer: relation between estrogen and progesterone receptors.
    Artero Morà A; Lluch Hernandez A; Cano Sanchez A; Bueno Cañigral FJ; Martin Quetglas G; Alberola Candel V; Garcia-Conde Bru J
    Tumori; 1989 Apr; 75(2):113-6. PubMed ID: 2741216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A; Milkov V
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoaffinity purification and characterisation of p29--an estrogen receptor related protein.
    Hayward JR; Coffer AI; King RJ
    J Steroid Biochem Mol Biol; 1990 Nov; 37(4):513-9. PubMed ID: 2278835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody to a 48 K antigen in oestrogen-dependent human breast cancer cells.
    Lewis JG; Robertson JM; Elder PA
    J Steroid Biochem; 1989 Aug; 33(2):171-8. PubMed ID: 2671504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid hormone receptors in breast tumours presenting during pregnancy or lactation.
    Holdaway IM; Mason BH; Kay RG
    J Surg Oncol; 1984 Jan; 25(1):38-41. PubMed ID: 6694391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fundamental research leading to improved endocrine therapy for breast cancer.
    Miller WR
    J Steroid Biochem; 1987; 27(1-3):477-85. PubMed ID: 3320538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody characterization of progesterone receptors, estrogen receptors and the stress-responsive protein of 27 kDa (SRP27) in human uterine leiomyoma.
    Navarro D; Cabrera JJ; Falcón O; Jiménez P; Ruiz A; Chirino R; López A; Rivero JF; Díaz-Chico JC; Díaz-Chico BN
    J Steroid Biochem; 1989; 34(1-6):491-8. PubMed ID: 2626044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors].
    Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B
    Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between oestrogen receptor,epidermal growth factor receptor, ER-D5, and P24 oestrogen regulated protein in human breast cancer.
    Horne GM; Angus B; Wright C; Needham G; Nicholson S; Harris AL; Innes B; Horne CH
    J Pathol; 1988 Jun; 155(2):143-50. PubMed ID: 3292735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are estrogen receptors cytoplasmic or nuclear? Some immunocytochemical and biochemical studies.
    Parikh I; Rajendran KG; Su JL; Lopez T; Sar M
    J Steroid Biochem; 1987; 27(1-3):185-92. PubMed ID: 3695480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.
    Vihko R; Alanko A; Isomaa V; Kauppila A
    Med Oncol Tumor Pharmacother; 1986; 3(3-4):197-210. PubMed ID: 3543533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are acquired nevi oestrogen-dependent tumours?
    Jemec GB; Bhogal BS; Wojnarowska F
    Acta Derm Venereol; 1987; 67(5):451-3. PubMed ID: 2449001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of oestrogen receptor-beta in invasive breast tumours].
    Péter I; Számel I; Péley G
    Magy Onkol; 2004; 48(1):63-9. PubMed ID: 15105898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.